A postmortem study to compare agonist and antagonist 5-HT1A receptor-binding sites in Alzheimer's disease.
about
Multitarget-directed tricyclic pyridazinones as G protein-coupled receptor ligands and cholinesterase inhibitors.Pharmacological agonists for more-targeted CNS radio-pharmaceuticals.The in vitro actions of loxapine on dopaminergic and serotonergic receptors. Time to consider atypical classification of this antipsychotic drug?
P2860
A postmortem study to compare agonist and antagonist 5-HT1A receptor-binding sites in Alzheimer's disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
A postmortem study to compare ...... sites in Alzheimer's disease.
@en
A postmortem study to compare ...... sites in Alzheimer's disease.
@nl
type
label
A postmortem study to compare ...... sites in Alzheimer's disease.
@en
A postmortem study to compare ...... sites in Alzheimer's disease.
@nl
prefLabel
A postmortem study to compare ...... sites in Alzheimer's disease.
@en
A postmortem study to compare ...... sites in Alzheimer's disease.
@nl
P2860
P50
P356
P1476
A postmortem study to compare ...... g sites in Alzheimer's disease
@en
P2093
Guillaume Becker
Nathalie Streichenberger
P2860
P304
P356
10.1111/CNS.12306
P577
2014-07-09T00:00:00Z